Page last updated: 2024-10-27

fluoxetine and Cerebral Palsy, Athetoid

fluoxetine has been researched along with Cerebral Palsy, Athetoid in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
de Albuquerque, GL1
Manhães-de-Castro, R1
Lacerda, DC1
Calado, CMSDS1
Bezerra de Morais, AT1
Visco, DB1
Manhães-de-Castro, FM1
Toscano, AE1

Other Studies

1 other study available for fluoxetine and Cerebral Palsy, Athetoid

ArticleYear
Neonatal treatment with fluoxetine alters locomotor activity and the cortical glial/neuron index in rats with cerebral palsy.
    Canadian journal of physiology and pharmacology, 2023, Jul-01, Volume: 101, Issue:7

    Topics: Animals; Cerebral Palsy; Fluoxetine; Locomotion; Motor Activity; Neuroglia; Neurons; Rats

2023